Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 to 60

Exploring how the locus coeruleus affects attention in healthy adults

Official title: Investigation of Locus Coeruleus Function in Sustained Attention

Run by University of California, Davis · NCT06041048 · Data updated 2026-11-12

This study is testing how a part of the brain called the locus coeruleus affects attention in healthy adults, using special imaging techniques and a medication to see if it makes a difference.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment40 (estimated)
SponsorUniversity of California, Davis
Academic / other
Locations1 site (Sacramento, California)
StatusRecruiting
StartedOctober 1, 2023
Main results expectedDecember 19, 2026
Study endsDecember 19, 2026
Registry record updatedJune 18, 2026
Trial IDNCT06041048 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are healthy adults aged 18 to 60 who are typically developing.

Probably not a fit

Patients with a history of schizophrenia, psychosis, or significant neurological disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to investigate the function of the locus coeruleus (LC), a brain region involved in attention and cognitive processes, by developing advanced imaging techniques to measure its activity. Using high-resolution magnetic resonance imaging (MRI) tailored for the brainstem, the researchers will assess the LC's role in sustained attention and goal-directed behavior. The study will also involve pharmacological manipulation with modafinil to confirm the functional activity of the LC. By improving methods to measure LC activity, the research seeks to enhance understanding of attentional control and its implications for mental health disorders.

Why it matters

Potential benefit: If successful, this study could lead to better understanding and treatment strategies for attention-related disorders.

How similar studies have gone: While studies have explored the locus coeruleus's role in attention, this approach using advanced imaging techniques is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Between the ages of 18 - 60 years of age,
* Typically developing, healthy adult

Exclusion Criteria:

* History of schizophrenia, other forms of psychosis,
* Specific or focal neurological disorder or severe alcohol or drug use disorder within the past 5 years
* History of left ventricular hypertrophy or in patients with mitral valve prolapse who have experienced the mitral valve prolapse syndrome when previously receiving CNS stimulants, or who have had recent history of myocardial infarction or unstable angina.
* Volunteers with known hypersensitivity to modafinil or armodafinil or its inactive ingredients
* Known allergy/sensitivity or any hypersensitivity to components of modafinil or its formulation
* Inability to swallow tablets or tolerate oral medication;
* Pregnant or nursing (participants will be required to have a negative pregnancy test)
* Contraindication for MRI scanning (metal implants, pacemakers, metal foreign bodies, or pregnancy)
* Use of psychotropic medication within the past week
* Claustrophobic and not comfortable being in a small space may also not want to participate

Where it's running

  • University of California, Davis
    Sacramento, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.